Home › Glioblastoma › New York › Queens
Glioblastoma clinical trials in Queens, NY
5 studies for Glioblastoma are looking for participants at sites in and around Queens (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
RecruitingPhase 2
- Northwell Health Center for Advanced Medicine - Brain Tumor Center, Lake Success · 9 mi away
Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma
RecruitingPhase 1
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Rockville Centre · 10 mi away
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
RecruitingPhase 1
- NYU Langone Hospital - Long Island, Mineola · 11 mi away
A Study of 177Lu-PSMA-617 in People With Gliomas
RecruitingPhase 1
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi away
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Hempstead · 12 mi away
Glioblastoma trials in other cities
- New York City, NY30 studies
- Boston, MA28 studies
- Houston, TX26 studies
- Los Angeles, CA24 studies
- Durham, NC20 studies
- San Francisco, CA17 studies
- Chicago, IL15 studies
- Washington, DC15 studies
- Columbus, OH14 studies
- Miami, FL14 studies
- Rochester, MN13 studies
- Jacksonville, FL13 studies
Other studies in Queens
- Breast Cancer64 studies
- Non-Small Cell Lung Cancer49 studies
- Colorectal Cancer31 studies
- Metastatic Cancer28 studies
- Ovarian Cancer28 studies
- Prostate Cancer27 studies
- Cancer (all types)26 studies
- Endometrial Cancer25 studies
- Lung Cancer22 studies
- Acute Myeloid Leukemia21 studies
- Multiple Myeloma20 studies
- Pancreatic Cancer20 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.